Since April 2017, Prof. dr. Hirsch has been appointed professor in Medicinal Chemistry at the University of Saarland, Saarbrücken (Germany). Most of the group members, are now working at the Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS).
Anna Hirsch was born in Germany and grew up in Luxembourg. She read Natural Sciences with a focus on Chemistry at the University of Cambridge. She spent her third year at the Massachusetts Institute of Technology doing a research project with Prof. Timothy Jamison on the total synthesis of amphidinolide T1.
For her Master’s project, she returned to Cambridge to develop the double conjugate addition of dithiols to propargylic carbonyl systems reaction in the group of Prof. Steven V. Ley.
She received her Ph.D. from the ETH Zurich in 2008. Her research was carried out in the group of Prof. François Diederich and was aimed at the rational design and the synthesis of the first inhibitors for an enzyme as a novel approach to treat malaria.
Subsequently, she joined the group of Prof. Jean-Marie Lehn at the Institut de Science et d’Ingénierie Supramoléculaires (ISIS) in Strasbourg, dealing with three different projects: understanding the nature of the reversibility of the Diels–Alder reaction, using a morphological switch to control catalysis and selectivity in an allosteric manner and the design and synthesis of dynamic polymers inspired by proteins.
Her work focuses on rational approaches to drug design.